Author:
Chang Min Cheol,Lee Byung Joo,Yang Dongseok,Kim Chung Reen,Park Donghwi,Kim Sunyoung
Abstract
Abstract
Introduction
Gait disturbance in central nervous system (CNS) demyelinating disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO) is one of the most troublesome problems that has a direct impact on the quality of life. However, the associations between gait disturbance and other clinical variables of these two diseases have not been fully elucidated.
Objective
This study aimed to evaluate gait disturbance using a computerized gait analysis system and its association with various clinical variables in patients with MS and NMO.
Methods
A total of 33 patients (14 with MS and 19 with NMO) with minor disabilities, who were able to walk independently and had passed their acute phase, were enrolled in the study. Gait analysis were performed using a computer-based instrumented walkway system. (Walk-way MG-1000, Anima, Japan) Clinical variables, such as disease duration, medication, body mass index (BMI), hand grip power, and muscle mass were recorded. The Montreal Cognitive Assessment (MOCA), Beck Depression Inventory score-II (BDI), and fatigue scale were measured using the Functional Assessment of Chronic Illness Therapy-fatigue scale (FACIT-fatigue) scale. A trained neurologist scored the Expanded Disability Status Scale (EDSS).
Results
Gait speed was the single parameter that showed a significant positive correlation with MOCA (p < 0.001). The stance phase time was the single parameter that showed a significant negative correlation with EDSS (p < 0.001). Hand grip strength showed a significant positive correlation with skeletal muscle mass as assessed by bioimpedance analysis (p < 0.05). The FACIT-fatigue scale score showed a significant negative correlation with the BDI (p < 0.001).
Conclusion
In our patients with MS/NMO with mild disability, cognitive impairment was significantly correlated with gait speed, and the degree of disability was significantly correlated with stance phase time. Our findings may imply that early detection of a decrease in gait speed and an increase in stance phase time can predict the progression of cognitive impairment in patients with MS/NMO with mild disability.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine
Reference33 articles.
1. Harris MK, Maghzi AH, Etemadifar M, Kelley RE, Gonzalez-Toledo E, Minagar A. Acute demyelinating disorders of the central nervous system. Curr Treat Options Neurol. 2009;11:55–63.
2. Filli L, Sutter T, Easthope CS, Killeen T, Meyer C, Reuter K, Lorincz L, Bolliger M, Weller M, Curt A, Straumann D, Linnebank M, Zorner B. Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time. Sci Rep. 2018;8:4984.
3. Cameron MH, Wagner JM. Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment. Curr Neurol Neurosci Rep. 2011;11:507–15.
4. Jonsdottir J, Lencioni T, Gervasoni E, Crippa A, Anastasi D, Carpinella I, Rovaris M, Cattaneo D, Ferrarin M. Improved gait of persons with multiple sclerosis after rehabilitation: effects on lower limb muscle synergies, push-off, and toe-clearance. Front Neurol. 2020;11:668.
5. Nogueira LA, Dos Santos LT, Sabino PG, Alvarenga RM, Santos Thuler LC. Factors for lower walking speed in persons with multiple sclerosis. Mult Scler Int. 2013;2013: 875648.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献